Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder

Mise à jour : Il y a 4 ans
Référence : NCT02046564

Femme et Homme

Extrait

To evaluate the efficacy and the safety of ASC-01 (aripiprazole/sertraline combination) compared to sertraline monotherapy in patients with major depressive disorders who have responded incompletely to sertraline monotherapy.


Critère d'inclusion

  • Major Depressive Disorder


Liens